Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Fuji
Johnson and Johnson
Argus Health
Accenture
Cantor Fitzgerald
Boehringer Ingelheim
Citi

Generated: September 19, 2018

DrugPatentWatch Database Preview

METHYLPREDNISOLONE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Methylprednisolone, and when can generic versions of Methylprednisolone launch?

Methylprednisolone is a drug marketed by Elkins Sinn, Organon Usa Inc, Duramed Pharms Barr, Heather, Jubilant Cadista, Par Pharm, Sandoz, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms Usa Inc, Akorn, Sagent Pharms, Sandoz Inc, Teva Pharms Usa, Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma Farmaceutica, Intl Medication, and Teva Parenteral. and is included in fifty-eight NDAs.

The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

Drug patent expirations by year for METHYLPREDNISOLONE
Pharmacology for METHYLPREDNISOLONE
Synonyms for METHYLPREDNISOLONE
.DELTA.1-6.alpha.-Methylhydrocortisone
(1S,2R,8S,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,8,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
(6?,11?)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
010M591
1-Dehydro-6alpha-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11?,17?,21-Trihydroxy-6?-methyl-1,4-pregnadiene-3,20-dione
11beta,17,21-trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
124684-EP2295426A1
124684-EP2295427A1
2639-EP2277861A1
2639-EP2286811A1
2639-EP2292595A1
2639-EP2295409A1
2639-EP2298778A1
2639-EP2305660A1
2639-EP2308562A2
2639-EP2314590A1
2639-EP2371811A2
4-08-00-03498 (Beilstein Handbook Reference)
570-35-4
6-alpha-Methylprednisolone
6-alpha-Methylprednisolone 100 microg/mL in Acetonitrile
6.alpha.-Methylprednisolone
6alpha-methyl prednisolone
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-Methylprednisolone base
6alpha-Methylprednisolone, >=98%
6alpha-Methylprednisolone, VETRANAL(TM), analytical standard
83-43-2
AB2000257
AC1L1N7A
ACN-037579
AK163190
AKOS015969744
AN-15368
Artisone-wyeth
BDBM50103616
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
C-21225
CAS-83-43-2
CCG-220279
CHEBI:6888
CHEMBL650
CPD000058330
CS-2246
D00407
D08PIQ
DB00959
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
DSSTox_CID_3300
DSSTox_GSID_23300
DSSTox_RID_76965
DTXSID7023300
EINECS 201-476-4
Esametone
Firmacort
GTPL7088
H972
HMS1568H20
HMS2090B13
HMS2095H20
HMS2230D16
HMS3259J04
HSDB 3127
HY-B0260
KS-1273
Lemod
LMST02030178
LS-118498
M1665
Medesone
Medixon
Medlone 21
medralone
Medrate
Medrol
Medrol (TN)
Medrol adt pak
Medrol dosepak
Medrol;Solu-Medrol;Medrone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone (JP17/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone [USP:INN:BAN:JAN]
Methylprednisolone & Salts
Methylprednisolone for system suitability A, EuropePharmacopoeia (EP) Reference Standard
Methylprednisolone for system suitability, European Pharmacopoeia (EP) Reference Standard
Methylprednisolone, 6-alpha
Methylprednisolone, European Pharmacopoeia (EP) Reference Standard
Methylprednisolone, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Methylprednisolone, United States Pharmacopeia (USP) Reference Standard
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MFCD00010591
MLS000028541
MLS001148159
MLS002207191
MLS002638721
Moderin
MolPort-002-528-554
NC00691
NCGC00016330-01
NCGC00022735-03
NCGC00022735-06
NCGC00255269-01
NCI60_001657
Nirypan
Noretona
NSC-19987
NSC19987
Opera_ID_1576
PL000308
Predni N Tablinen
Prednisolone, 6.alpha.-methyl-
Prednisolone, 6alpha-methyl-
Prednisolone, methyl-
Prednol- L
Pregna-1,20-dione, 11,17,21-trihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-
Pregna-1,20-dione, 6.alpha.-methyl-11.beta.-17,21-trihydroxy-
Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6a,11b)-
Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6alpha,11beta)-
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Pregna-1,4-diene-3,20-dione, 6-alpha-methyl-11-beta-17,21-trihydroxy-
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Q-201395
Reactenol
s1733
SAM002589984
SC-15861
SCHEMBL5084
Sieropresol
SMR000058330
Solomet
SPBio_002377
SR-01000003089
SR-01000003089-2
ST24048101
Summicort
Summicort;
Suprametil
Tox21_110376
Tox21_110376_1
Tox21_302018
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
VHRSUDSXCMQTMA-PJHHCJLFSA-N
Wyacort
X4W7ZR7023
ZINC3875560

US Patents and Regulatory Information for METHYLPREDNISOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 202691-001 Feb 16, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 085374-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040794-001 Mar 5, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 086953-001 Jul 22, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089143-001 Mar 28, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 207667-003 Dec 15, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Fuji
Johnson and Johnson
Argus Health
Accenture
Cantor Fitzgerald
Boehringer Ingelheim
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.